Sign In
Buy PBIO
$0.0047
+0 (+0%)
At Close: Jul 31, 2026
Uncle Bud's, PBIO's New Consumer Products Business Unit, Kicks Off 2024 with a $252,000 Shipment of Sunburn Soother to One of the World's Largest Retailers Uncle Bud's, PBIO's New Consumer Products B
SOUTH EASTON, Mass.--(BUSINESS WIRE)--Pressure BioSciences (OTCQB: PBIO) Strategically Acquires Leading Health & Wellness Firm Uncle Bud's Hemp and CBD.
SOUTH EASTON, Mass.--(BUSINESS WIRE)--Pressure BioSciences (OTCQB: PBIO) Strategically Acquires Leading Health & Wellness Firm Uncle Bud's Hemp and CBD.
Artificial Intelligence/Machine Learning Also Expected to Significantly Accelerate Advancements in PBIO's Patented, Innovative, and Enabling UltraShear Processing Platform SOUTH EASTON, MA / ACCESSWIR
Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced Nanomaterials SOUTH EASTON, M
Novel Results Published in Respected Peer-Reviewed Food Science and Emerging Technologies Journal - Discussions Underway with Beverage Industry Companies SOUTH EASTON, MA / ACCESSWIRE / December 12, 2
Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of the Agreement. "Valor CBD" Topical Spray Now Available on the VST Website.
Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
09:28am, Tuesday, 21'st Nov 2023
Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / November 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
09:15am, Monday, 20'th Nov 2023
Conference Call Scheduled for Tuesday, November 21 at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / November 20, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced t
World-Renowned Researchers Validate that UltraShear-Processed CBD Nanoemulsions Deliver CBD with Absorption Speed and 4X Bioavailability in Bloodstream vs. Existing Edible CBD Consumer Products SOUTH
Scientists at Lonza Biologics and Pressure BioSciences Presented PBIO's Patented BaroFold Platform for Breakthrough Efficiency and Economics Versus Current Manufacturing Methods in the Nearly $500 Bil
Bioscreen Instruments Launches Distribution of PBIO's PCT Instruments and Consumables into Third Largest Pharmaceutical and Largest Global Supply Sectors of Generic Medicines Worldwide; Expects Strong
Pressure BioSciences, Inc. (PBIO) Q4 2022 Earnings Call Transcript
09:21pm, Tuesday, 18'th Apr 2023
Pressure BioSciences, Inc. (PBIO) Q4 2022 Earnings Call Transcript
7 Stocks to Sell Right Now
01:11pm, Friday, 18'th Nov 2022
Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I'm just going to stic
Company Shifts Primary Business Focus to Revolutionary UST Platform. Expects to Enter FY 2023 with Ten or More Tolling Contracts.
